Drug Profile
Research programme: tau protein positron emission tomography tracers - AC Immune/Life Molecular Imaging
Alternative Names: 18F-Tau; Tau-PET imaging agents - AC Immune/Life Molecular Imaging; Tau-PET tracerLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator AC Immune
- Developer AC Immune; Life Molecular Imaging
- Class Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in Alzheimer's-disease(Diagnosis) in Switzerland (Parenteral)
- 12 May 2014 Preclinical trials in Alzheimer's disease (diagnosis) in Switzerland (Parenteral)